237 related articles for article (PubMed ID: 29428841)
1. Nitrite potentiates the vasodilatory signaling of S-nitrosothiols.
Liu T; Zhang M; Terry MH; Schroeder H; Wilson SM; Power GG; Li Q; Tipple TE; Borchardt D; Blood AB
Nitric Oxide; 2018 May; 75():60-69. PubMed ID: 29428841
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.
Liu T; Schroeder HJ; Zhang M; Wilson SM; Terry MH; Longo LD; Power GG; Blood AB
Nitric Oxide; 2016 Aug; 58():20-7. PubMed ID: 27235767
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols.
Liu T; Schroeder HJ; Wilson SM; Terry MH; Romero M; Longo LD; Power GG; Blood AB
Free Radic Biol Med; 2016 Feb; 91():215-23. PubMed ID: 26686469
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
5. H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells.
Ondrias K; Stasko A; Cacanyiova S; Sulova Z; Krizanova O; Kristek F; Malekova L; Knezl V; Breier A
Pflugers Arch; 2008 Nov; 457(2):271-9. PubMed ID: 18458940
[TBL] [Abstract][Full Text] [Related]
6. Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide.
Cortese-Krott MM; Fernandez BO; Santos JL; Mergia E; Grman M; Nagy P; Kelm M; Butler A; Feelisch M
Redox Biol; 2014; 2():234-44. PubMed ID: 24494198
[TBL] [Abstract][Full Text] [Related]
7. Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities.
Dalsgaard T; Simonsen U; Fago A
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3072-8. PubMed ID: 17307993
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and S-nitroso-L-cysteine as endothelium-derived relaxing factors from acetylcholine in cerebral vessels in cats.
Kukreja RC; Wei EP; Kontos HA; Bates JN
Stroke; 1993 Dec; 24(12):2010-4; discussion 2014-5. PubMed ID: 8248984
[TBL] [Abstract][Full Text] [Related]
9. Nitroso-sulfide coupled signaling triggers specific vasoactive effects in the intrarenal arteries of patients with arterial hypertension.
Cacanyiova S; Berenyiova A; Balis P; Kristek F; Grman M; Ondrias K; Breza J; Breza J
J Physiol Pharmacol; 2017 Aug; 68(4):527-538. PubMed ID: 29151069
[TBL] [Abstract][Full Text] [Related]
10. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Sogo N; Campanella C; Webb DJ; Megson IL
Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
12. Nitrite- and nitroxyl-induced relaxation in porcine coronary (micro-) arteries: underlying mechanisms and role as endothelium-derived hyperpolarizing factor(s).
Botden IP; Batenburg WW; de Vries R; Langendonk JG; Sijbrands EJ; Danser AH
Pharmacol Res; 2012 Nov; 66(5):409-18. PubMed ID: 22902525
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery.
Nozik-Grayck E; Whalen EJ; Stamler JS; McMahon TJ; Chitano P; Piantadosi CA
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L136-43. PubMed ID: 16126786
[TBL] [Abstract][Full Text] [Related]
14. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: Correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases.
Arai RJ; Ogata FT; Batista WL; Masutani H; Yodoi J; Debbas V; Augusto O; Stern A; Monteiro HP
Toxicol Appl Pharmacol; 2008 Dec; 233(2):227-37. PubMed ID: 18786557
[TBL] [Abstract][Full Text] [Related]
16. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
[TBL] [Abstract][Full Text] [Related]
17. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction.
Perrin-Sarrado C; Zhou Y; Salgues V; Parent M; Giummelly P; Lartaud I; Gaucher C
Biochem Pharmacol; 2020 Mar; 173():113686. PubMed ID: 31678494
[TBL] [Abstract][Full Text] [Related]
18. The effects of thiol modulators on nitrergic nerve- and S-nitrosothiols-induced relaxation in duodenum.
Kıroğlu OE; Aydinoglu F; Oğülener N
J Basic Clin Physiol Pharmacol; 2013; 24(2):143-50. PubMed ID: 23412870
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.
Jiang H; Polhemus DJ; Islam KN; Torregrossa AC; Li Z; Potts A; Lefer DJ; Bryan NS
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):478-85. PubMed ID: 26746429
[TBL] [Abstract][Full Text] [Related]
20. The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP.
Kumari S; Sammut IA; Giles GI
Eur J Pharmacol; 2014 Aug; 737():168-76. PubMed ID: 24858367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
